IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q4 2019 Holdings

Filed 2020-02-14 | 16 holdings | $206.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Personalis(PSNL)Common71535D106$59.3K5,449,29428.7%
Phathom(PHAT)Common71722W107$37.4K1,203,13518.1%
Crispr(CRSP)NAMEN AKTH17182108$31.6K519,19815.3%
SientraCommon82621J105$21.3K2,390,84310.3%
SolenoCommon834203200$19.9K6,969,2729.6%
Exicure(XCUR)Common30205M101$19.9K6,977,0009.6%
Verona(VRNA)SPONDS ADR925050106$5.2K901,9432.5%
ParatekCommon699374302$4.2K1,041,1312.0%
Molecular TemplatesCommon608550109$2.8K200,0001.4%
Aeglea(AGLEUSD)Common00773J103$1.8K240,5000.9%
Chiasma(CHMA)Common16706W102$1.8K370,6710.9%
ProteonCommon74371L109$8792,144,5170.4%
ObsevaCommonH5861P103$33587,9990.2%
Cymabay(CBAYUSD)Common23257D103$256131,0360.1%
Sierra OncologyCommon82640U107$74216,6670.0%
OcugenCommon43358V109$47,1110.0%